Are you Dr. Ma?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 8 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
200 Hawkins Dr
C606gh University Of Iowa Hospitals-Dept Of Pathology
Iowa City, IA 52242Phone+1 319-384-5700Fax+1 319-356-4916
Summary
- Dr. Deqin Ma, MD is a board certified pathologist in Iowa City, Iowa. She is currently licensed to practice medicine in Iowa, Pennsylvania, and Maryland. She is affiliated with University of Iowa Hospitals and Clinics and is an Assistant Professor at University of Iowa College of Medicine.
Education & Training
- University of Texas M D Anderson Cancer CenterFellowship, Molecular Genetic Pathology, 2009 - 2010
- National Institutes of Health Clinical CenterResidency, Pathology-Anatomic and Clinical, 2006 - 2009
- Shandong Medical UniversityClass of 1988
Certifications & Licensure
- IA State Medical License 2011 - 2026
- MD State Medical License 2008 - 2011
- PA State Medical License 2010 - 2011
- American Board of Pathology Pathology - Anatomic
- American Board of Pathology Pathology - Molecular Genetic
Publications & Presentations
PubMed
- Unveiling RACK1: a key regulator of the PI3K/AKT pathway in prostate cancer development.Cancan Lyu, Prasanna Kuma Vaddi, Said Elshafae, Anirudh Pradeep, Deqin Ma
Oncogene. 2025-02-01 - 3 citationsMolecular characterization and survival analysis of a cohort of glioblastoma, IDH-wildtype.Bilge Dundar, Mouaz Alsawas, Amr Masaadeh, Kyle Conway, Anthony N Snow
Pathology, Research and Practice. 2024-05-01 - 2 citationsRecurrent TRAK1::RAF1 Fusions in pediatric low-grade gliomas.Jamal K Benhamida, Hannah J Harmsen, Deqin Ma, Christopher M William, Bryan K Li
Brain Pathology. 2023-09-01